Insider Ledger

LEGN insider buying and SEC filings, explained

Legend Biotech Corp · CIK 1801198

Tracked: Forms 3/4/5, 8-K, NT · Limited coverage: files 6-K/20-F, not covered in v1 · All filings on sec.gov

Company profile

Exchanges
Nasdaq
Industry (SIC)
Pharmaceutical Preparations
State of incorporation
E9
Fiscal year end
Dec 31

Insider activity in the last 12 months

Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$567K
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Sep 29, 2026SaleCorazon (Corsee) D. Sanders (Director) sold 27,370 shares at about $9.46 ($259K). Holdings down 34% to 52,731 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Oct 1, 2026, 4:04 PM ET
Sep 21, 2026SaleCarlos E Santos (CFO) sold 5,430 shares at about $9.14 ($50K). Holdings down 28% to 14,246 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 23, 2026
Jun 30, 2026SalePatrick John Casey (Director) sold 6,000 shares at $14.80 ($89K). Holdings down 11% to 48,604 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jul 2, 2026
Jun 25, 2026SaleYing Huang (CEO and Director) sold 5,566 shares at about $14.78 ($82K). Holdings down 2% to 241,872 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jun 29, 2026
Mar 25, 2026SaleYing Huang (CEO and Director) sold 9,936 shares at about $8.77 ($87K). Holdings down 4% to 247,438 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Mar 27, 2026

10 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow LEGN in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app